These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22126913)

  • 41. Microglia, inflammation and gut microbiota responses in a progressive monkey model of Parkinson's disease: A case series.
    Joers V; Masilamoni G; Kempf D; Weiss AR; Rotterman TM; Murray B; Yalcin-Cakmakli G; Voll RJ; Goodman MM; Howell L; Bachevalier J; Green SJ; Naqib A; Shaikh M; Engen PA; Keshavarzian A; Barnum CJ; Nye JA; Smith Y; Tansey MG
    Neurobiol Dis; 2020 Oct; 144():105027. PubMed ID: 32712266
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Restoration of dopamine transporter density in the striatum of fetal ventral mesencephalon-grafted, but not sham-grafted, MPTP-treated parkinsonian monkeys.
    Elsworth JD; Brittan MS; Taylor JR; Sladek JR; al-Tikriti MS; Zea-Ponce Y; Innis RB; Redmond DE; Roth RH
    Cell Transplant; 1996; 5(2):315-25. PubMed ID: 8689042
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Severe long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the vervet monkey (Cercopithecus aethiops sabaeus).
    Taylor JR; Elsworth JD; Roth RH; Sladek JR; Redmond DE
    Neuroscience; 1997 Dec; 81(3):745-55. PubMed ID: 9316026
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
    Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH
    J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential regulation of striatal dopamine D(1) and D(2) receptors in acute and chronic parkinsonian monkeys.
    Decamp E; Wade T; Schneider JS
    Brain Res; 1999 Nov; 847(1):134-8. PubMed ID: 10564746
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduced noradrenaline, but not dopamine and serotonin in motor thalamus of the MPTP primate: relation to severity of parkinsonism.
    Pifl C; Hornykiewicz O; Blesa J; Adánez R; Cavada C; Obeso JA
    J Neurochem; 2013 Jun; 125(5):657-62. PubMed ID: 23331162
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Brain α7 nicotinic acetylcholine receptors in MPTP-lesioned monkeys and parkinsonian patients.
    Morissette M; Morin N; Grégoire L; Rajput A; Rajput AH; Di Paolo T
    Biochem Pharmacol; 2016 Jun; 109():62-69. PubMed ID: 27038656
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changes in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy.
    Jourdain VA; Morin N; Grégoire L; Morissette M; Di Paolo T
    J Neurosurg; 2015 Dec; 123(6):1383-93. PubMed ID: 25932606
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuronal loss in the caudal intralaminar thalamic nuclei in a primate model of Parkinson's disease.
    Villalba RM; Wichmann T; Smith Y
    Brain Struct Funct; 2014 Jan; 219(1):381-94. PubMed ID: 23508713
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reproducibility of a Parkinsonism-related metabolic brain network in non-human primates: A descriptive pilot study with FDG PET.
    Ma Y; Johnston TH; Peng S; Zuo C; Koprich JB; Fox SH; Guan Y; Eidelberg D; Brotchie JM
    Mov Disord; 2015 Aug; 30(9):1283-8. PubMed ID: 26377152
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations.
    Ko JH; Lee CS; Eidelberg D
    J Cereb Blood Flow Metab; 2017 Feb; 37(2):683-693. PubMed ID: 26980757
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Circadian determinations of cortisol, prolactin and melatonin in chronic methyl-phenyl-tetrahydropyridine-treated monkeys.
    Barcia C; Bautista V; Sánchez-Bahillo A; Fernández-Villalba E; Navarro-Ruis JM; Barreiro AF; Poza Y Poza M; Herrero MT
    Neuroendocrinology; 2003 Aug; 78(2):118-28. PubMed ID: 12915764
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PET imaging of implanted human retinal pigment epithelial cells in the MPTP-induced primate model of Parkinson's disease.
    Doudet DJ; Cornfeldt ML; Honey CR; Schweikert AW; Allen RC
    Exp Neurol; 2004 Oct; 189(2):361-8. PubMed ID: 15380486
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Mitchell IJ; Clarke CE; Boyce S; Robertson RG; Peggs D; Sambrook MA; Crossman AR
    Neuroscience; 1989; 32(1):213-26. PubMed ID: 2586750
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of MPTP on Serotonergic Neuronal Systems and Mitochondrial Complex I Activity in the Living Brain: A PET Study on Conscious Rhesus Monkeys.
    Kanazawa M; Ohba H; Nishiyama S; Kakiuchi T; Tsukada H
    J Nucl Med; 2017 Jul; 58(7):1111-1116. PubMed ID: 28280215
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The neurophysiology and effect of deep brain stimulation in a patient with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism.
    Christine CW; Langston JW; Turner RS; Starr PA
    J Neurosurg; 2009 Feb; 110(2):234-8. PubMed ID: 19099380
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 99mTc-TRODAT-1 SPECT in healthy and 6-OHDA lesioned parkinsonian monkeys: comparison with 18F-FDOPA PET.
    Huang WS; Ma KH; Chou YH; Chen CY; Liu RS; Liu JC
    Nucl Med Commun; 2003 Jan; 24(1):77-83. PubMed ID: 12501023
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Progressive loss of striatal dopamine terminals in MPTP-induced acute parkinsonism in cynomolgus monkeys using vesicular monoamine transporter type 2 PET imaging ([(18)F]AV-133).
    Liu Y; Yue F; Tang R; Tao G; Pan X; Zhu L; Kung HF; Chan P
    Neurosci Bull; 2014 Jun; 30(3):409-16. PubMed ID: 24061965
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dopamine replacement therapy reverses abnormal synchronization of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of parkinsonism.
    Heimer G; Bar-Gad I; Goldberg JA; Bergman H
    J Neurosci; 2002 Sep; 22(18):7850-5. PubMed ID: 12223537
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo measures of nigrostriatal neuronal response to unilateral MPTP treatment.
    Tian L; Karimi M; Brown CA; Loftin SK; Perlmutter JS
    Brain Res; 2014 Jul; 1571():49-60. PubMed ID: 24845719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.